Small molecule valproic acid enhances ventral patterning of human neural tube organoids by regulating Wnt and Shh signalling
Cell Proliferation · 2025
DOI: 10.1111/cpr.13737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2025. Verfasst von Yuanyuan Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Information Materials and Intelligent Sensing Laboratory of Anhui Province, Institute of Physical Science and Information Technology, Anhui Universit…. Hauptthemen laut MEDLINE: Valproic Acid, Hedgehog Proteins, Neural Tube, Organoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Joint Funds of the National Natural Science Foundation of China, Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
Valproic acid (VPA), a clinically approved small molecule, has been reported to activate Wnt signalling that is critical for dorsal–ventral (DV) patterning of neural tube. However, little is known about the impact of VPA on DV patterning process. Here, we show that even though VPA has a negative impact on the early formation of human neural tube organoids (hNTOs), it significantly enhances the efficiency of ventrally patterned hNTOs, when VPA is added during the entire differentiation process. RNA sequencing and RT‐qPCR analysis demonstrates VPA activates endogenous Wnt signalling in hNTOs. Surprisingly, transcriptome analysis also identifies upregulation of genes for degradation of GLI2 and GLI3 proteins, whose truncated fragment are transcriptional repressors of Shh signalling. The Western‐blot analysis confirms the increase of GLI3R proteins after VPA treatment. Thus, VPA might enhance ventral patterning of hNTOs through both activating Wnt, which can antagonise Shh signalling by inducing GLI3 expression, and/or inhibiting Shh signalling by inducing GLI protein degradation. We further obtain results to show that VPA still increases patterning efficiency of hNTOs with a weak influence on their early formation when the initiation time of VPA is delayed and its duration is reduced. Taken together, this study demonstrates that VPA enhances the generation of more reproducible hNTOs with ventral patterning, opening the avenues for the applications of hNTOs in developmental biology and regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Information Materials and Intelligent Sensing Laboratory of Anhui Province, Institute of Physical Science and Information Technology, Anhui University, Hefei, China.
- Department of Mechanical Engineering, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Cell & Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Lijun Wu
Förderung
- National Natural Science Foundation of China
- Joint Funds of the National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
- Advanced Innovative Programs for the Returned Overseas Chinese Scholars in Anhui province
Zitieren
APA
Zheng, Y., Zhang, F., Nie, H., Li, X., Xun, J., Fu, J., & Wu, L. (2025). Small molecule valproic acid enhances ventral patterning of human neural tube organoids by regulating Wnt and Shh signalling. Cell Proliferation. https://doi.org/10.1111/cpr.13737
Vancouver
Zheng Y, Zhang F, Nie H, Li X, Xun J, Fu J, et al. Small molecule valproic acid enhances ventral patterning of human neural tube organoids by regulating Wnt and Shh signalling. Cell Proliferation. 2025. doi:10.1111/cpr.13737
BibTeX
@article{Zheng2025,
author = {Zheng, Yuanyuan and Zhang, Fangrong and Nie, Haifeng and Li, Xinyu and Xun, Jiali and Fu, Jianping and Wu, Lijun},
title = {Small molecule valproic acid enhances ventral patterning of human neural tube organoids by regulating Wnt and Shh signalling},
journal = {Cell Proliferation},
year = {2025},
doi = {10.1111/cpr.13737}
}
EUVIMED